scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.JCONREL.2012.03.016 |
P698 | PubMed publication ID | 22709414 |
P50 | author | Malou Henriksen-Lacey | Q37840518 |
Dennis Christensen | Q37840535 | ||
Jan Pravsgaard Christensen | Q43182017 | ||
Peter Andersen | Q54029065 | ||
Thomas Lindenstrøm | Q56884096 | ||
Claire-Anne Siegrist | Q64006386 | ||
Yvonne Perrie | Q91734501 | ||
Else Marie Agger | Q111279894 | ||
Karen Smith Korsholm | Q117250581 | ||
Arun T. Kamath | Q117250583 | ||
Paul-Henri Lambert | Q117250585 | ||
P2093 | author name string | Anne-Francoise Rochat | |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | immunologic adjuvant | Q967453 |
P304 | page(s) | 468-476 | |
P577 | publication date | 2012-06-01 | |
P1433 | published in | Journal of Controlled Release | Q6295046 |
P1476 | title | A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog | |
P478 | volume | 160 |
Q38098855 | A case-study investigating the physicochemical characteristics that dictate the function of a liposomal adjuvant |
Q91440678 | A lipidic delivery system of a triple vaccine adjuvant enhances mucosal immunity following nasal administration in mice |
Q40805619 | A novel liposome adjuvant DPC mediates Mycobacterium tuberculosis subunit vaccine well to induce cell-mediated immunity and high protective efficacy in mice |
Q37332628 | Adjuvant effect of cationic liposomes for subunit influenza vaccine: influence of antigen loading method, cholesterol and immune modulators |
Q41678461 | Cationic liposomal sodium stibogluconate (SSG), a potent therapeutic tool for treatment of infection by SSG-sensitive and -resistant Leishmania donovani |
Q95482822 | Cell recruitment and antigen trafficking in afferent lymph after injection of antigen and poly(I:C) containing liposomes, in aqueous or oil-based formulations |
Q48695533 | Clearance of depot vaccine SPIO-labeled antigen and substrate visualized using MRI. |
Q36500269 | Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens |
Q59798720 | Dual-Isotope SPECT/CT Imaging of the Tuberculosis Subunit Vaccine H56/CAF01: Induction of Strong Systemic and Mucosal IgA and T-Cell Responses in Mice Upon Subcutaneous Prime and Intrapulmonary Boost Immunization |
Q35593603 | Formulation, high throughput in vitro screening and in vivo functional characterization of nanoemulsion-based intranasal vaccine adjuvants |
Q36154772 | Harnessing nanoparticles for immune modulation |
Q54211947 | Induction of Cytotoxic T-Lymphocyte Responses Upon Subcutaneous Administration of a Subunit Vaccine Adjuvanted With an Emulsion Containing the Toll-Like Receptor 3 Ligand Poly(I:C). |
Q61803783 | Induction of Plasmodium-Specific Immune Responses Using Liposome-Based Vaccines |
Q26765446 | Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators |
Q38068245 | Liposome-based delivery system for vaccine candidates: constructing an effective formulation. |
Q34418761 | Liposomes as vaccine delivery systems: a review of the recent advances |
Q54690087 | Manufacturing Methods for Liposome Adjuvants. |
Q42724009 | Modern Vaccines/Adjuvants Formulation Session 6: Vaccine &Adjuvant Formulation & Production 15-17 May 2013, Lausanne, Switzerland |
Q36909492 | Novel adjuvant formulations for delivery of anti-tuberculosis vaccine candidates |
Q42235032 | Novel vaccine delivery system induces robust humoral and cellular immune responses based on multiple mechanisms |
Q52655234 | Overcoming the Neonatal Limitations of Inducing Germinal Centers through Liposome-Based Adjuvants Including C-Type Lectin Agonists Trehalose Dibehenate or Curdlan. |
Q35664854 | Properties and prospects of adjuvants in influenza vaccination - messy precipitates or blessed opportunities? |
Q37834166 | Systematic Investigation of the Role of Surfactant Composition and Choice of oil: Design of a Nanoemulsion-Based Adjuvant Inducing Concomitant Humoral and CD4+ T-Cell Responses. |
Q89783316 | Targeted Delivery of Mannosylated Nanoparticles Improve Prophylactic Efficacy of Immersion Vaccine against Fish Viral Disease |
Q45831503 | Th1 immune responses can be modulated by varying dimethyldioctadecylammonium and distearoyl-sn-glycero-3-phosphocholine content in liposomal adjuvants |
Q49829267 | The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases |
Q39190589 | The in vivo expressed Mycobacterium tuberculosis (IVE-TB) antigen Rv2034 induces CD4⁺ T-cells that protect against pulmonary infection in HLA-DR transgenic mice and guinea pigs |
Search more.